In 2010, Masuzawa et al reported the results of a phase I/II clinical trial in which the safety of vaccination with VEGFR1 and VEGFR2 peptide combined with S-1 and cisplatin was demonstrated in patients with advanced gastric cancer (21). The gene discussed is FLT1; the disease is gastric cancer.